STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • June 14th, 2017 • Minerva Neurosciences, Inc. • Pharmaceutical preparations • Delaware
This Stock Repurchase Agreement (this “Agreement”) is made and entered into as of June 13, 2017, by and among Minerva Neurosciences, Inc., a Delaware corporation (the “Company”), and Johnson & Johnson Innovation – JJDC, Inc. (f/k/a Johnson & Johnson Development Corporation), a New Jersey corporation (the “Seller”).
AMENDMENT NO. 1 TO CO-DEVELOPMENT AND LICENSE AGREEMENTCo-Development and License Agreement • June 14th, 2017 • Minerva Neurosciences, Inc. • Pharmaceutical preparations • New York
This AMENDMENT NO. 1 TO CO-DEVELOPMENT AND LICENSE AGREEMENT (this “Amendment”), dated as of June 13, 2017 (the “Amendment Execution Date”), is made by and between Janssen Pharmaceutica NV, a corporation organized and existing under the laws of Belgium (“Janssen”) and Minerva Neurosciences, Inc., a corporation organized under the laws of the State of Delaware (“Minerva”). Janssen and Minerva are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
